Dissecting racial disparities in the treatment of patients with locoregional pancreatic cancer: A 2-step process

Taylor S. Riall, Courtney Townsend, Yong Fang Kuo, Jean L. Freeman, James Goodwin

Research output: Contribution to journalArticle

37 Citations (Scopus)

Abstract

BACKGROUND: Previous studies have demonstrated that black patients with pancreatic cancer are less likely to undergo resection and have worse overall survival compared with white patients. The objective of this study was to determine whether these disparities occur at the point of surgical evaluation or after evaluation has taken place. METHODS: The authors used the Surveillance, Epidemiology, and End Results (SEER)-Medicare linked data (1992-2002) to compare black patients and white patients with locoregional pancreatic cancer in univariate models. Logistic regression was used to determine the effect of race on surgical evaluation and on surgical resection after evaluation. Cox proportional hazards models were used to identify which factors influenced 2-year survival. RESULTS: Nine percent of 3777 patients were black. Blacks were substantially less likely than whites to undergo evaluation by a surgeon (odds ratio, 0.57; 95% confidence interval, 0.42-0.77) when the model was adjusted for demographics, tumor characteristics, surgical evaluation, socioeconomic status, and year of diagnosis. Patients who were younger and who had fewer comorbidities, abdominal imaging, and a primary care physician were more likely to undergo surgical evaluation. Once they were seen by a surgeon, blacks still were less likely than whites to undergo resection (odds ratio, 0.64; 95% confidence interval, 0.49-0.84). Although black patients had decreased survival in an unadjusted model, race no longer was significant after accounting for resection. CONCLUSIONS: Twenty-nine percent of black patients with potentially resectable pancreatic cancers never received surgical evaluation. Without surgical evaluation, patients cannot make an informed decision and will not be offered resection. Attaining higher rates of surgical evaluation in black patients would be the first step to eliminating the observed disparity in the resection rate.

Original languageEnglish (US)
Pages (from-to)930-939
Number of pages10
JournalCancer
Volume116
Issue number4
DOIs
StatePublished - Feb 15 2010

Fingerprint

Pancreatic Neoplasms
varespladib methyl
Therapeutics
Survival
Odds Ratio
Confidence Intervals
Primary Care Physicians
Medicare
Proportional Hazards Models
Social Class
Comorbidity
Epidemiology
Logistic Models
Demography

Keywords

  • Pancreatic cancer
  • Racial disparities
  • Resectability
  • Surgical evaluation
  • Surgical resection

ASJC Scopus subject areas

  • Cancer Research
  • Oncology

Cite this

Dissecting racial disparities in the treatment of patients with locoregional pancreatic cancer : A 2-step process. / Riall, Taylor S.; Townsend, Courtney; Kuo, Yong Fang; Freeman, Jean L.; Goodwin, James.

In: Cancer, Vol. 116, No. 4, 15.02.2010, p. 930-939.

Research output: Contribution to journalArticle

@article{c9b6cd16bf62435fac7335a9dd9de7da,
title = "Dissecting racial disparities in the treatment of patients with locoregional pancreatic cancer: A 2-step process",
abstract = "BACKGROUND: Previous studies have demonstrated that black patients with pancreatic cancer are less likely to undergo resection and have worse overall survival compared with white patients. The objective of this study was to determine whether these disparities occur at the point of surgical evaluation or after evaluation has taken place. METHODS: The authors used the Surveillance, Epidemiology, and End Results (SEER)-Medicare linked data (1992-2002) to compare black patients and white patients with locoregional pancreatic cancer in univariate models. Logistic regression was used to determine the effect of race on surgical evaluation and on surgical resection after evaluation. Cox proportional hazards models were used to identify which factors influenced 2-year survival. RESULTS: Nine percent of 3777 patients were black. Blacks were substantially less likely than whites to undergo evaluation by a surgeon (odds ratio, 0.57; 95{\%} confidence interval, 0.42-0.77) when the model was adjusted for demographics, tumor characteristics, surgical evaluation, socioeconomic status, and year of diagnosis. Patients who were younger and who had fewer comorbidities, abdominal imaging, and a primary care physician were more likely to undergo surgical evaluation. Once they were seen by a surgeon, blacks still were less likely than whites to undergo resection (odds ratio, 0.64; 95{\%} confidence interval, 0.49-0.84). Although black patients had decreased survival in an unadjusted model, race no longer was significant after accounting for resection. CONCLUSIONS: Twenty-nine percent of black patients with potentially resectable pancreatic cancers never received surgical evaluation. Without surgical evaluation, patients cannot make an informed decision and will not be offered resection. Attaining higher rates of surgical evaluation in black patients would be the first step to eliminating the observed disparity in the resection rate.",
keywords = "Pancreatic cancer, Racial disparities, Resectability, Surgical evaluation, Surgical resection",
author = "Riall, {Taylor S.} and Courtney Townsend and Kuo, {Yong Fang} and Freeman, {Jean L.} and James Goodwin",
year = "2010",
month = "2",
day = "15",
doi = "10.1002/cncr.24836",
language = "English (US)",
volume = "116",
pages = "930--939",
journal = "Cancer",
issn = "0008-543X",
publisher = "John Wiley and Sons Inc.",
number = "4",

}

TY - JOUR

T1 - Dissecting racial disparities in the treatment of patients with locoregional pancreatic cancer

T2 - A 2-step process

AU - Riall, Taylor S.

AU - Townsend, Courtney

AU - Kuo, Yong Fang

AU - Freeman, Jean L.

AU - Goodwin, James

PY - 2010/2/15

Y1 - 2010/2/15

N2 - BACKGROUND: Previous studies have demonstrated that black patients with pancreatic cancer are less likely to undergo resection and have worse overall survival compared with white patients. The objective of this study was to determine whether these disparities occur at the point of surgical evaluation or after evaluation has taken place. METHODS: The authors used the Surveillance, Epidemiology, and End Results (SEER)-Medicare linked data (1992-2002) to compare black patients and white patients with locoregional pancreatic cancer in univariate models. Logistic regression was used to determine the effect of race on surgical evaluation and on surgical resection after evaluation. Cox proportional hazards models were used to identify which factors influenced 2-year survival. RESULTS: Nine percent of 3777 patients were black. Blacks were substantially less likely than whites to undergo evaluation by a surgeon (odds ratio, 0.57; 95% confidence interval, 0.42-0.77) when the model was adjusted for demographics, tumor characteristics, surgical evaluation, socioeconomic status, and year of diagnosis. Patients who were younger and who had fewer comorbidities, abdominal imaging, and a primary care physician were more likely to undergo surgical evaluation. Once they were seen by a surgeon, blacks still were less likely than whites to undergo resection (odds ratio, 0.64; 95% confidence interval, 0.49-0.84). Although black patients had decreased survival in an unadjusted model, race no longer was significant after accounting for resection. CONCLUSIONS: Twenty-nine percent of black patients with potentially resectable pancreatic cancers never received surgical evaluation. Without surgical evaluation, patients cannot make an informed decision and will not be offered resection. Attaining higher rates of surgical evaluation in black patients would be the first step to eliminating the observed disparity in the resection rate.

AB - BACKGROUND: Previous studies have demonstrated that black patients with pancreatic cancer are less likely to undergo resection and have worse overall survival compared with white patients. The objective of this study was to determine whether these disparities occur at the point of surgical evaluation or after evaluation has taken place. METHODS: The authors used the Surveillance, Epidemiology, and End Results (SEER)-Medicare linked data (1992-2002) to compare black patients and white patients with locoregional pancreatic cancer in univariate models. Logistic regression was used to determine the effect of race on surgical evaluation and on surgical resection after evaluation. Cox proportional hazards models were used to identify which factors influenced 2-year survival. RESULTS: Nine percent of 3777 patients were black. Blacks were substantially less likely than whites to undergo evaluation by a surgeon (odds ratio, 0.57; 95% confidence interval, 0.42-0.77) when the model was adjusted for demographics, tumor characteristics, surgical evaluation, socioeconomic status, and year of diagnosis. Patients who were younger and who had fewer comorbidities, abdominal imaging, and a primary care physician were more likely to undergo surgical evaluation. Once they were seen by a surgeon, blacks still were less likely than whites to undergo resection (odds ratio, 0.64; 95% confidence interval, 0.49-0.84). Although black patients had decreased survival in an unadjusted model, race no longer was significant after accounting for resection. CONCLUSIONS: Twenty-nine percent of black patients with potentially resectable pancreatic cancers never received surgical evaluation. Without surgical evaluation, patients cannot make an informed decision and will not be offered resection. Attaining higher rates of surgical evaluation in black patients would be the first step to eliminating the observed disparity in the resection rate.

KW - Pancreatic cancer

KW - Racial disparities

KW - Resectability

KW - Surgical evaluation

KW - Surgical resection

UR - http://www.scopus.com/inward/record.url?scp=76249092818&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=76249092818&partnerID=8YFLogxK

U2 - 10.1002/cncr.24836

DO - 10.1002/cncr.24836

M3 - Article

C2 - 20052726

AN - SCOPUS:76249092818

VL - 116

SP - 930

EP - 939

JO - Cancer

JF - Cancer

SN - 0008-543X

IS - 4

ER -